CNS & Neurological Disorders - Drug Targets
Title:Editorial (Thematic Issue: New Therapeutic Options for Anxiety and Mood Disorders)
Volume: 13 Issue: 6
Author(s): Antonio Egidio Nardi and Sergio Machado
Affiliation:
Export Options
About this article
Cite this article as:
Nardi Egidio Antonio and Machado Sergio, Editorial (Thematic Issue: New Therapeutic Options for Anxiety and Mood Disorders), CNS & Neurological Disorders - Drug Targets 2014; 13 (6) . https://dx.doi.org/10.2174/187152731306140903113807
DOI https://dx.doi.org/10.2174/187152731306140903113807 |
Print ISSN 1871-5273 |
Publisher Name Bentham Science Publisher |
Online ISSN 1996-3181 |
33
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Vasculogenic and Angiogenic Pathways in Moyamoya Disease
Current Medicinal Chemistry Is alpha-Synuclein Pathology a Target for Treatment of Neurodegenerative Disorders?
Current Alzheimer Research Evoked Potential in Panic Disorder Patients: A Systematic Review
CNS & Neurological Disorders - Drug Targets Acute Effects of a Single, Oral dose of d9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) Administration in Healthy Volunteers
Current Pharmaceutical Design Meet Our Editorial Board Member
Current Neuropharmacology Phosphodiesterase Inhibitors as a Target for Cognition Enhancement in Aging and Alzheimer’s Disease: A Translational Overview
Current Pharmaceutical Design Gene Therapy for Osteoinduction
Current Gene Therapy Trypanothione Reductase: A Target for the Development of Anti- Trypanosoma cruzi Drugs
Mini-Reviews in Medicinal Chemistry Label-Free Cell Phenotypic Assays for Assessing Drug Polypharmacology
Current Pharmaceutical Design Synthesis, EGFR Inhibition and Anti-cancer Activity of New 3,6-dimethyl-1-phenyl-4-(substituted-methoxy)pyrazolo[3,4-d] pyrimidine Derivatives
Anti-Cancer Agents in Medicinal Chemistry Enteric Ecosystem Disruption in Autism Spectrum Disorder: Can the Microbiota and Macrobiota be Restored?
Current Pharmaceutical Design The Ambivalence of Early Diagnosis – Returning Results in Current Alzheimer Research
Current Alzheimer Research Aging, Mitochondria and Male Reproductive Function
Current Aging Science Assessment of the Autonomic Response in Alzheimer's Patients During the Execution of Memory Tasks: A Functional Thermal Imaging Study
Current Alzheimer Research Midkine: A Promising Molecule for Drug Development to Treat Diseases of the Central Nervous System
Current Pharmaceutical Design The Role of CXCR3 in Neurological Diseases
Current Neuropharmacology Sleep Disorders Research From 1945 to 2020: A Bibliometric Analysis
CNS & Neurological Disorders - Drug Targets Fibrosis as a Therapeutic Target Post-Myocardial Infarction
Current Pharmaceutical Design Nogo Receptor Interacts with Brain APP and Aβ to Reduce Pathologic Changes in Alzheimers Transgenic Mice
Current Alzheimer Research Meet Our Editors
Medicinal Chemistry